Viewing Study NCT05868395


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT05868395
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2023-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma
Sponsor: Medical University of Vienna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module